Pfizer Inc. (PFE) — Stock analysis
USDCurrent price
26,17 USD
0,03 USD (+0.11%) today
Market signals
About Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical companies, focused on vaccines (Prevnar, Comirnaty with BioNTech), oncology (Ibrance, Xtandi), rare diseases, and inflammation/immunology. After the 2021-2022 revenue peak from the Covid vaccine and Paxlovid, the company has gone through significant readjustment. The Seagen acquisition (2023, $43 billion) strengthened the oncology pipeline. Headquartered in New York City.
What does Pfizer do?▾
Pfizer produces drugs and vaccines across several areas: pneumococcal vaccines (Prevnar) and Covid (Comirnaty), oncology (Ibrance, Xtandi, plus Seagen therapies), rare diseases, immunology, inflammation and neuroscience.
Does Pfizer pay dividends?▾
Yes, but with some complications. It pays a historically reliable quarterly dividend. In recent years payout ratio has risen above 100% due to post-Covid earnings decline: the dividend is sustainable from cash but the safety margin has narrowed. 2024-2026 yield typically 5.5-7%.
What happened after the Covid peak?▾
In 2021-2022 revenue climbed above $100 billion thanks to the vaccine and Paxlovid. Since 2023 the decline in Covid-related demand has brought revenue below $60 billion. Future growth depends on the oncology pipeline (Seagen), new RSV vaccines, and new phase-III drugs. The stock reflects the market's (variable) assessment of how much of this pipeline will materialize.
Analyse this stock with AI
Create a free account and get 2 credits to generate a complete analysis.
Create account · 2 free credits